The Value of Serum CD62P and sTREM-1 Levels in Predicting the Occurrence of Major Cardiovascular Adverse Events in Elderly Patients with Coronary Heart Disease After PCI

YIN Zhang, FU Yongbo, ZHU Dongmei, FAN Yang, XUN Jinlin

PDF(1241 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1241 KB)
Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (3) : 491-495. DOI: 10.11748/bjmy.issn.1006-1703.2024.03.018
Clinical Investigation

The Value of Serum CD62P and sTREM-1 Levels in Predicting the Occurrence of Major Cardiovascular Adverse Events in Elderly Patients with Coronary Heart Disease After PCI

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(3): 491-495 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.03.018

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1241 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉